No Data
No Data
Express News | Pharmather Holdings Ltd - FDA Has No Concern About Stability of Ketamine Submission Batches
Express News | Pharmather Holdings Ltd - FDA Requests New and Updated Information on Drug Substance and Manufacturing
Express News | Pharmather Holdings Ltd - Initiates Activities to Address Crl Deficiencies
Express News | Pharmather Holdings Ltd - FDA Schedules Post-Complete Letter Clarification Meeting for December 2, 2024
PharmaTher Holdings Ltd: MDA AMENDED EN
PharmaTher's Sairiyo Therapeutics Gets OK to Initiate a Phase 1 Human Clinical Trial of PD-001 (Reformulated Cepharanthine)
No Data